# K060728: Novabone Putty - Bioactive Synthetic Graft

- Pathway: 510(k) (Traditional)
- Applicant: Novabone Products, LLC
- Decided: May 1, 2006 after 45 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K960978 (1996). 8 ancestors in all.
120 later devices descend from it; 14 cite it directly.
0 of 129 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K021336: Novabone-Resorbable Bone Graft Substitute, Novabone Products, LLC (2002) Summary page 1.
- K020078: Exactech Resorbable Bone Paste, Exactech, Inc. (2004) Summary page 1.
- K051195: Grafton DBM, Osteotech, Inc. (2005)

## Most influential descendants
- K080009: Novabone Putty- Bioactive Synthetic Graft (2008), 71 descendants of its own
- K082672: Novabone Putty-Bioactive Synthetic Bone Graft (2008), 59 descendants of its own
- K072184: Vitoss Bioactive Foam Bone Graft Substitute (2007), 51 descendants of its own
- K081439: Vitoss Bioactive Foam Pack Bone Graft Substitute (2008), 50 descendants of its own
- K101860: Novabone Putty- Bioactive Synthetic Bone Graft (2010), 47 descendants of its own

## Indications for use
NovaBone Putty - Bioactive Synthetic Graft is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. NovaBone Putty is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e. the extremities and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K060728
Methodology: https://510kreport.com/methodology